asparagine has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, WL; Yuan, C | 1 |
| Che, H; Duan, Q; Li, Q; Ren, J; Song, K; Wang, X; Yang, C; Yi, J; Yu, H | 1 |
2 other study(ies) available for asparagine and dinoprostone
| Article | Year |
|---|---|
A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus.
Topics: Amino Acid Sequence; Animals; Asparagine; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Dinoprostone; Endoplasmic Reticulum; Endoplasmic Reticulum-Associated Degradation; Fibroblasts; Glycosylation; Golgi Apparatus; Group IV Phospholipases A2; HEK293 Cells; Humans; Immunoblotting; Intramolecular Oxidoreductases; Isoquinolines; Leupeptins; Mice; Microscopy, Confocal; Mutation; NIH 3T3 Cells; Prostaglandin-E Synthases; Protein Kinase Inhibitors; Protein Transport; Sulfonamides | 2015 |
Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acid; Asparagine; Butanes; Cell Proliferation; Dinoprost; Dinoprostone; Glutamic Acid; Humans; Leukotriene B4; Luteolin; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Network Pharmacology; Ornithine; Oxaloacetates; Prostaglandin D2; Pulmonary Arterial Hypertension; Rats | 2022 |